Author:
Prasad Rajendra,Kaur Gurjit
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
2. Bodnar AG, Quellette M, Frolkis M, et al. Extension of life span by introduction of telomerase into normal human cells. Science. 1998;279:349–52.
3. Pal D, Sharma U, Prasad R. Therapeutic anticancer approaches targeting telomerase and telomere. In: Gandhi V, Mehta K, Grover R, Pathak S, Aggarwal A, Bharat B, editors. Multitargeted approach to treatment of cancer. Berlin: Springer; 2015.
4. Ali JH, Walter M. Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate complete and combinatory attack (TICC). Cancer Cell Int. 2023;23:197.
5. Conomos D, Pickett HA, Reddel RR. Aletrnative lengthening of telomeres: remodelling the telomere architecture. Front Oncol. 2013;3:27.